Insider · CIK 0001320559

Cook Anne Marie

Reports to the SEC for 4 companies · FLORHAM PARK, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001320559

Forms 4 and 5

Insider transactions

46 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-02-10	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Legal Off. & Corp. Sec.	AAward	+3,461 sh	—	—	90,195
2026-02-10	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Chief Legal Off. & Corp. Sec.	FTax Payment	−1,535 sh	$12.82	−$19.7K	88,660
2026-01-02	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Legal Off. & Corp. Sec.	AAward	+75.3K sh	—	—	85,012
2026-01-02	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Off. & Corp. Sec.	AAward	+67.9K sh	—	—	67,878
2025-12-17	PHATPhathom Pharmaceuticals, Inc.F Tax Payment	Chief Legal Off. & Corp. Sec.	FTax Payment	−7,703 sh	$15.36	−$118K	9,667
2025-12-17	PHATPhathom Pharmaceuticals, Inc.A Award	Chief Legal Off. & Corp. Sec.	AAward	+17.4K sh	—	—	17,370
2025-06-23	PHATPhathom Pharmaceuticals, Inc. · Stock Option (Right to Buy)A Award	Chief Legal Off. & Corp. Sec.	AAward	+210K sh	—	—	210,000
2024-08-05	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+13.5K sh	—	—	28,543
2024-08-05	Sage Therapeutics, Inc.F Tax Payment	SVP, GC & Secretary	FTax Payment	−4,503 sh	$8.96	−$40.3K	24,040
2024-02-13	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+11.3K sh	—	—	25,181
2024-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+22.5K sh	—	—	22,500
2023-11-28	Sage Therapeutics, Inc.F Tax Payment	SVP, GC & Secretary	FTax Payment	−1,174 sh	$19.27	−$22.6K	13,716
2023-11-28	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+4,000 sh	—	—	14,890
2023-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+19K sh	—	—	19,000
2023-02-03	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+2,850 sh	—	—	11,478
2023-02-03	Sage Therapeutics, Inc.F Tax Payment	SVP, GC & Secretary	FTax Payment	−980 sh	$44.16	−$43.3K	10,498
2022-02-11	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+15.2K sh	—	—	15,200
2021-10-19	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+3,800 sh	—	—	9,010
2021-10-19	Sage Therapeutics, Inc.F Tax Payment	SVP, GC & Secretary	FTax Payment	−1,116 sh	$40.29	−$45K	7,894
2021-06-15	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+4,000 sh	—	—	6,117
2021-06-15	Sage Therapeutics, Inc.F Tax Payment	SVP, GC & Secretary	FTax Payment	−1,144 sh	$58.80	−$67.3K	4,973
2021-02-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+19K sh	—	—	19,000
2020-04-28	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+9,450 sh	—	—	9,450
2020-02-12	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+20K sh	—	—	20,000
2019-07-25	Sage Therapeutics, Inc.F Tax Payment	SVP, GC & Secretary	FTax Payment	−844 sh	$161.38	−$136K	1,756
2019-07-25	Sage Therapeutics, Inc.A Award	SVP, GC & Secretary	AAward	+1,900 sh	—	—	2,600
2019-06-21	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+9,240 sh	—	—	18,480
2019-05-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−700 sh	—	—	109,300
2019-05-10	Sage Therapeutics, Inc.Stock Option (Right to Buy)M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	−15K sh	—	—	15,000
2019-05-10	Sage Therapeutics, Inc.M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+700 sh	$56.27	+$39.4K	700
2019-05-10	Sage Therapeutics, Inc.S Sale	SVP, GC & Secretary	SSale	−15K sh	$166.14	−$2.49M	0
2019-05-10	Sage Therapeutics, Inc.M Exercise/Conversion	SVP, GC & Secretary	MExercise/Conversion	+15K sh	$28.63	+$429K	15,000
2019-02-13	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+19K sh	—	—	19,000
2018-12-07	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+9,240 sh	—	—	9,240
2018-04-02	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+31.5K sh	—	—	31,500
2017-02-06	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+56K sh	—	—	56,000
2016-12-08	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+10K sh	—	—	40,000
2016-02-08	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+40K sh	—	—	40,000
2015-09-16	Sage Therapeutics, Inc.Stock Option (Right to Buy)A Award	SVP, GC & Secretary	AAward	+110K sh	—	—	110,000
2015-08-04	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, General Counsel	AAward	+40K sh	—	—	40,000
2015-04-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, General Counsel	AAward	+40K sh	—	—	40,000
2015-04-01	Aegerion Pharmaceuticals, Inc.Restricted Stock UnitsA Award	SVP, General Counsel	AAward	+10K sh	—	—	10,000
2014-12-31	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, General Counsel	AAward	+45K sh	—	—	45,000
2013-04-01	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, General Counsel	AAward	+20K sh	—	—	20,000
2012-01-03	Aegerion Pharmaceuticals, Inc.Stock Option (right to buy)A Award	SVP, General Counsel	AAward	+115K sh	—	—	115,000
2005-09-21	VIACELL INCEmployee Stock Option (right to buy)A Award	General Counsel, SVP of Legal	AAward	+75K sh	—	—	75,000

Recent filings

Accepted (ET)
Feb 124
Cook Anne Marie0001193125-26-048881
SEC(opens sec.gov)
Jan 24
Cook Anne Marie0001193125-26-001125
SEC(opens sec.gov)
Dec 194
Cook Anne Marie0001193125-25-327131
SEC(opens sec.gov)
Jun 244
Cook Anne Marie0000950170-25-089513
SEC(opens sec.gov)
Aug 74
Cook Anne Marie0001562180-24-006087
SEC(opens sec.gov)
Feb 154
Cook Anne Marie0001562180-24-001335
SEC(opens sec.gov)
Nov 304
Cook Anne Marie0001562180-23-007978
SEC(opens sec.gov)
Feb 154
Cook Anne Marie0001562180-23-001423
SEC(opens sec.gov)
Feb 74
Cook Anne Marie0001562180-23-001080
SEC(opens sec.gov)
Feb 154
Cook Anne Marie0001562180-22-001474
SEC(opens sec.gov)
Oct 214
Cook Anne Marie0001562180-21-006598
SEC(opens sec.gov)
Jun 174
Cook Anne Marie0001562180-21-004341
SEC(opens sec.gov)

Companies

Address

C/O PHATHOM PHARMACEUTICALS, INC. 100 CAMPUS DRIVE, SUITE 102

FLORHAM PARK, NJ, 07932